Izvoz spreman — 

Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodiumglucose cotransporter-2 (SGLT2) inhibitors showed profound reno-protective effe...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
格式: Artigo
語言:Inglês
出版: The Korean Society of Nephrology 2020-09-01
叢編:Kidney Research and Clinical Practice
主題:
diabetes mellitus
type 2
glomerular filtration rate
renal function
sodium-glucose transporter-2 inhibitors
在線閱讀:https://doi.org/10.23876/j.krcp.20.132
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍